ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
223 hedge funds and large institutions have $3.31B invested in Array Biopharma Inc in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 88 increasing their positions, 76 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
27% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 37
Holders
223
Holding in Top 10
6
Calls
$23.1M
Puts
$24.3M
Top Buyers
| 1 | +$33.7M | |
| 2 | +$32.7M | |
| 3 | +$26.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.5M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$17.2M |
Top Sellers
| 1 | -$49.8M | |
| 2 | -$31.4M | |
| 3 | -$20.9M | |
| 4 |
PC
PointState Capital
New York
|
-$15.9M |
| 5 |
Goldman Sachs
New York
|
-$15.2M |